vs

Side-by-side financial comparison of Knight-Swift Transportation Holdings Inc. (KNX) and Moderna (MRNA). Click either name above to swap in a different company.

Knight-Swift Transportation Holdings Inc. is the larger business by last-quarter revenue ($1.9B vs $1.0B, roughly 1.8× Moderna). Knight-Swift Transportation Holdings Inc. runs the higher net margin — 0.0% vs -19.7%, a 19.7% gap on every dollar of revenue. On growth, Knight-Swift Transportation Holdings Inc. posted the faster year-over-year revenue change (1.4% vs -45.4%). Knight-Swift Transportation Holdings Inc. produced more free cash flow last quarter ($56.9M vs $-880.0M). Over the past eight quarters, Knight-Swift Transportation Holdings Inc.'s revenue compounded faster (0.1% CAGR vs -45.0%).

Swift Transportation is an American truckload motor shipping carrier based in Phoenix, Arizona. In 2017, Swift merged with Knight Transportation, also of Phoenix, forming Knight-Swift.

Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA (mRNA) to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".

KNX vs MRNA — Head-to-Head

Bigger by revenue
KNX
KNX
1.8× larger
KNX
$1.9B
$1.0B
MRNA
Growing faster (revenue YoY)
KNX
KNX
+46.9% gap
KNX
1.4%
-45.4%
MRNA
Higher net margin
KNX
KNX
19.7% more per $
KNX
0.0%
-19.7%
MRNA
More free cash flow
KNX
KNX
$936.9M more FCF
KNX
$56.9M
$-880.0M
MRNA
Faster 2-yr revenue CAGR
KNX
KNX
Annualised
KNX
0.1%
-45.0%
MRNA

Income Statement — Q1 FY2026 vs Q3 FY2025

Metric
KNX
KNX
MRNA
MRNA
Revenue
$1.9B
$1.0B
Net Profit
$96.0K
$-200.0M
Gross Margin
79.6%
Operating Margin
1.5%
-25.6%
Net Margin
0.0%
-19.7%
Revenue YoY
1.4%
-45.4%
Net Profit YoY
-76.6%
-1638.5%
EPS (diluted)
$-0.01
$-0.51

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
KNX
KNX
MRNA
MRNA
Q1 26
$1.9B
Q4 25
$1.9B
Q3 25
$1.9B
$1.0B
Q2 25
$1.9B
Q1 25
$1.8B
Q4 24
$1.9B
$966.0M
Q3 24
$1.9B
$1.9B
Q2 24
$1.8B
Net Profit
KNX
KNX
MRNA
MRNA
Q1 26
$96.0K
Q4 25
$-6.8M
Q3 25
$7.9M
$-200.0M
Q2 25
$34.2M
Q1 25
$30.6M
Q4 24
$69.5M
$-1.1B
Q3 24
$30.5M
$13.0M
Q2 24
$20.3M
Gross Margin
KNX
KNX
MRNA
MRNA
Q1 26
Q4 25
Q3 25
79.6%
Q2 25
Q1 25
Q4 24
23.5%
Q3 24
72.4%
Q2 24
Operating Margin
KNX
KNX
MRNA
MRNA
Q1 26
1.5%
Q4 25
1.4%
Q3 25
2.6%
-25.6%
Q2 25
3.9%
Q1 25
3.7%
Q4 24
4.2%
-129.0%
Q3 24
4.3%
-3.8%
Q2 24
3.4%
Net Margin
KNX
KNX
MRNA
MRNA
Q1 26
0.0%
Q4 25
-0.4%
Q3 25
0.4%
-19.7%
Q2 25
1.8%
Q1 25
1.7%
Q4 24
3.7%
-115.9%
Q3 24
1.6%
0.7%
Q2 24
1.1%
EPS (diluted)
KNX
KNX
MRNA
MRNA
Q1 26
$-0.01
Q4 25
$-0.04
Q3 25
$0.05
$-0.51
Q2 25
$0.21
Q1 25
$0.19
Q4 24
$0.43
$-2.91
Q3 24
$0.19
$0.03
Q2 24
$0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
KNX
KNX
MRNA
MRNA
Cash + ST InvestmentsLiquidity on hand
$222.8M
$1.1B
Total DebtLower is stronger
Stockholders' EquityBook value
$7.1B
$9.3B
Total Assets
$11.9B
$12.1B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
KNX
KNX
MRNA
MRNA
Q1 26
$222.8M
Q4 25
$220.4M
Q3 25
$192.7M
$1.1B
Q2 25
$216.3M
Q1 25
$209.5M
Q4 24
$218.3M
$1.9B
Q3 24
$166.3M
$1.6B
Q2 24
$186.5M
Total Debt
KNX
KNX
MRNA
MRNA
Q1 26
Q4 25
$1.7B
Q3 25
$1.9B
Q2 25
$1.8B
Q1 25
$1.8B
Q4 24
$1.8B
Q3 24
$1.9B
Q2 24
$1.6B
Stockholders' Equity
KNX
KNX
MRNA
MRNA
Q1 26
$7.1B
Q4 25
$7.1B
Q3 25
$7.1B
$9.3B
Q2 25
$7.1B
Q1 25
$7.1B
Q4 24
$7.1B
$10.9B
Q3 24
$7.1B
$11.9B
Q2 24
$7.1B
Total Assets
KNX
KNX
MRNA
MRNA
Q1 26
$11.9B
Q4 25
$12.0B
Q3 25
$12.6B
$12.1B
Q2 25
$12.5B
Q1 25
$12.6B
Q4 24
$12.7B
$14.1B
Q3 24
$12.8B
$15.8B
Q2 24
$12.6B
Debt / Equity
KNX
KNX
MRNA
MRNA
Q1 26
Q4 25
0.25×
Q3 25
0.26×
Q2 25
0.26×
Q1 25
0.26×
Q4 24
0.26×
Q3 24
0.26×
Q2 24
0.23×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
KNX
KNX
MRNA
MRNA
Operating Cash FlowLast quarter
$142.5M
$-847.0M
Free Cash FlowOCF − Capex
$56.9M
$-880.0M
FCF MarginFCF / Revenue
3.1%
-86.6%
Capex IntensityCapex / Revenue
4.6%
3.2%
Cash ConversionOCF / Net Profit
1484.79×
TTM Free Cash FlowTrailing 4 quarters
$-1.9B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
KNX
KNX
MRNA
MRNA
Q1 26
$142.5M
Q4 25
$723.2M
Q3 25
$217.5M
$-847.0M
Q2 25
$216.5M
Q1 25
$109.4M
Q4 24
$274.3M
$825.0M
Q3 24
$214.0M
$-1.6B
Q2 24
$273.4M
Free Cash Flow
KNX
KNX
MRNA
MRNA
Q1 26
$56.9M
Q4 25
Q3 25
$-880.0M
Q2 25
Q1 25
Q4 24
$303.0M
Q3 24
$-1.7B
Q2 24
FCF Margin
KNX
KNX
MRNA
MRNA
Q1 26
3.1%
Q4 25
Q3 25
-86.6%
Q2 25
Q1 25
Q4 24
31.4%
Q3 24
-92.2%
Q2 24
Capex Intensity
KNX
KNX
MRNA
MRNA
Q1 26
4.6%
Q4 25
Q3 25
3.2%
Q2 25
Q1 25
Q4 24
54.0%
Q3 24
8.1%
Q2 24
Cash Conversion
KNX
KNX
MRNA
MRNA
Q1 26
1484.79×
Q4 25
Q3 25
27.67×
Q2 25
6.32×
Q1 25
3.57×
Q4 24
3.95×
Q3 24
7.03×
-120.46×
Q2 24
13.47×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

KNX
KNX

Revenue, excluding truckload and LTL fuel surcharge$1.6B89%
Truckload and LTL fuel surcharge$212.2M11%

MRNA
MRNA

COVID19$971.0M96%
Other Revenue$20.0M2%
Grant$14.0M1%
Collaboration Arrangement Including Arrangements With Affiliate$7.0M1%
License And Royalty$2.0M0%

Related Comparisons